Phanerochaete chrysosporium Burdsall
Phanerochaete chrysosporium Burdsall
规格:
货期:
编号:TS178110
品牌:Testobio
| 产品名称： | Phanerochaete chrysosporium Burdsall |
|---|---|
| 商品货号： | TS178110 |
| Deposited As： | Phanerochaete chrysosporium Burdsall, teleomorph |
| Strain Designations： | LN 3576 FPL 11894 |
| Alternate State： | Sporotrichum pulverulentum Novobranova, Sporotrichum pruinosum Gilman et Abbott |
| Application： | produces spirolaxine produces spirolaxine methyl ether |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 323: Malt agar medium |
| Growth Conditions： | Temperature: 25.0°C |
| Name of Depositor： | Pfizer, Inc. |
| U.S. Patent Number： | |
| References： | Guadliana MA, et al. Process for preparing spirolaxine and spirolaxine methyl ether. US Patent 6,074,855 dated Jun 13 2000 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
Phanerochaete chrysosporium Burdsall
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Phanerochaete chrysosporium Burdsall |
|---|---|
| 商品货号： | TS178110 |
| Deposited As： | Phanerochaete chrysosporium Burdsall, teleomorph |
| Strain Designations： | LN 3576 FPL 11894 |
| Alternate State： | Sporotrichum pulverulentum Novobranova, Sporotrichum pruinosum Gilman et Abbott |
| Application： | produces spirolaxine produces spirolaxine methyl ether |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 323: Malt agar medium |
| Growth Conditions： | Temperature: 25.0°C |
| Name of Depositor： | Pfizer, Inc. |
| U.S. Patent Number： | |
| References： | Guadliana MA, et al. Process for preparing spirolaxine and spirolaxine methyl ether. US Patent 6,074,855 dated Jun 13 2000 |
